骨量

  • 网络Bone mass;BMD;Pbm
骨量骨量
  1. 比如,宇航员的骨量会下降。

    For instance , astronauts lose bone mass .

  2. 1α(OH)-D3对去势大鼠下颌骨骨量变化的影响

    The effects of 1 α( OH ) - D_3 on bone mass of mandibles in ovariectomized rats

  3. 结果A组感染控制及骨修复均良好,感染控制率、再生骨量明显优于B组;

    Results The rates of bone infection controlled of group A was superior to that of group B or C.

  4. 维生素K对幼鼠骨量及骨强度影响的实验研究

    Effect of various levels of vitamin K intake on parameters of bone metrology and biomechanics in rats

  5. 目的评价防治骨质疏松症药物1α(OH)-D3如何影响下颌骨的骨量变化。

    Objective To evaluate the protecting effects of 1 α( OH ) - D 3 on mandibular bone loss .

  6. 螺旋CT可以提供种植区骨量和骨密度的信息,对种植术前设计具有重要意义。

    Spiral CT is a useful tool for determining the bone quantity and bone density , it is important for preoperative design .

  7. 组织形态计量分析:4周和8周,各实验组的成骨量无显著差异(P>0.05);

    Histomorphology analysis : 4 weeks and 8 weeks , the quantity of bone formation has no significant difference among 3 experimental groups ( P > 0.05 );

  8. IGF-1是维持骨量和促进骨细胞生长的重要因子。

    IGF-1 is important factor which maintained bone mass and promoted bone cells growth .

  9. 观察Graves病患者骨量减少和骨质疏松的患病情况,并对男性与女性患者的患病情况、各年龄组之间的患病情况进行比较。

    We observed the morbidity of osteopenia and osteoporosis in patients with Graves ' disease . 2 .

  10. 目的:通过定量CT(QCT)检查,了解骨密度(BMD)的变化情况,以期对骨量减少及骨质疏松症(OP)的早期诊断和防治为临床提供帮助。

    Purpose : Quantitative CT adjust bone mineral density measurement to be help for clinical diagnostic and prevention .

  11. 但由于个体差异,建议修复前先行螺旋CT影像学检查,评估颧骨的形态和骨量,以提高种植的安全性和有效性。

    In order to improve security and validity of implantation , it is better to take spiral CT examination to evaluate the bone volume and shape of zygomatic body before zygomatic-area implant .

  12. STI作为骨质量的综合评价指标,对早期RA病人的骨量丢失也有一定的意义。

    As a comprehensive index , STI has some meaning to bone loss in the early RA patients .

  13. 同时IGF-1抑制间质中胶原酶转录,减少骨胶原降解,维持骨量。

    IGF-1 also inhibited the transcription of interstitial collagenase to reduce collagen degradation , that maintained bone mass .

  14. 骨质疏松症(Osteoporosis)是一种以低骨量和骨组织微结构破坏为特征,导致骨骼脆性增加和易发生骨折的全身性疾病。

    As for Osteoporosis , its essential characters are low bone content and the destroyed micro-framework which can increase bone brittleness and easily fracture .

  15. 单纯服用钙剂不能治疗PMO,且继续骨量丢失。

    However calcium tablet can not prevent the loss of bone .

  16. 小剂量间歇性给予PTH可以增加骨形成,使骨量上升。

    Intermittent PTH treatment at low dosage will help bone formation and increase bone mass .

  17. 小剂量的氟制剂能中度增加骨量,用氟治疗6个月BMD就可有统计学意义。

    A little dose of fluoride can moderately increase the bone mass , BMD could show statistically significance in 6 months .

  18. 自体骨块移植和Bio-Oss骨粉在上前牙区骨量不足种植术中的应用

    Autotransplantation with Bone Block and Bio - Oss in Upper Anterior Implant

  19. 但还有一部分研究未能证实VDR基因多态性与骨量的关联。

    But some studies show no association between vitamin D receptor gene polymorphism and bone mass .

  20. 骨矿密度(BMD)是诊断骨量减少(低骨量,骨质疏松),评价骨丢失率和疗效的重要客观指标。

    Bone mineral density ( BMD ) is widely used to measure bone loss and assess effectiveness of treatments for osteoporosis by WHO .

  21. 结论:跟骨定量超声BUA测值减低可反映早期RA骨量丢失的程度及评价疾病的活动性。

    Conclusion : BUA could reflect bone loss degree and evaluate disease activity in early RA patients .

  22. 握力运动对Colles骨折患者桡骨骨量的影响

    Effect of gripping exercise on the radius bone mass of patients with Colles fracture

  23. 骨组织形态计量学:O组比S组、E组和A组骨结合率、松质骨区骨量明显下降,结果有统计学意义。E组、A组与S组未有统计学差异。

    Histomorphometry showed that the combination ratio of bone surface with implant in group O decreased significantly compared with E , group A and S , among which there were no significant statistical differences .

  24. ALN组PTM,LV骨量增加(P<0.001),完全对抗OVX大鼠的骨高转换。

    There were increased bone mass of PTM and LV in the ALN group ( P < 0.001 ) .

  25. 结果:88例20-40岁月经规律妇女中腰椎和双髋部BMD在正常范围者76例,出现骨量减少者12例;

    Results : BMD of the lumbar spines and both hips were normal in 76 members of the 88 aged 20-40 years menstruating normally .

  26. 有些疾病可以通过增加OB的数量或增强OB的活性而引起骨量的增加。

    Some diseases can increase the number of OBs or enhance the activity of OBs caused an increase in bone mass .

  27. 62岁轻微骨量减少女性的椎体,L2~4骨质增生,椎间隙欠清楚。

    Vertebral body of female with slight reduction of bone mass of 62 years old , hyperosteogeny of L2-4 , and intervertebral space was not clear .

  28. 结论:BSP对AIS患者骨异常代谢及骨量降低的影响不大,非胶原结构蛋白可能不是AIS患者骨代谢研究的首要考虑对象;

    Conclusion : The abnormal bone mineral status in AIS patients may not be directly linked to abnormalities in the non-collagen proteins like BSP .

  29. 结果A组实验侧具有高效的骨诱导活性,其成骨量显著高于对照组B、C、D及空白对照组。

    Results In the experimental groups with PLA / rhBMP / BMSc , the activity and new bone quantity were significantly higher than that in group B , C , and D and the single control group ( P < 0.01 ) .

  30. 1研究背景骨质疏松症(Osteoporosis,OP)是一种以全身性的骨量及骨组织结构改变,伴有骨脆性增加和易骨折的疾病。

    Background : Osteoporosis ( Osteoporosis , OP ) is a systemic bone mass and bone structure change , accompanied by osteopsathyrosis increase and the fracture of the disease .